To determine whether peptide therapy is a good fit for your specific situation, schedule a consultation with a DripGym physician
Introducing three peptides simultaneously makes it impossible to identify which one caused a side effect
Proper storage ensures consistent results across weekly dosing studies
We encourage you to speak to your BPI team about this, and to ask about resources available through the medical system to help you navigate this process
Key pathophysiologic mechanisms include: Mucosal barrier dysfunction: Impaired epithelial tight junctions allow bacterial translocation, triggering innate immune activation T-helper cell dysregulation: Predominantly Th1 and Th17 pathways drive chronic inflammation via TNF-, IL-12, IL-23 the basis for biologic therapy targets Transmural inflammation: Unlike UC (mucosal only), CD involves all layers: mucosa submucosa muscularis propria serosa Granuloma formation: Non-caseating granulomas are pathognomonic but present in only ~3050% of biopsies Fibrosis and stricture: Chronic inflammation activates myofibroblasts collagen deposition luminal narrowing obstructive symptoms Fistula formation: Transmural ulcers penetrate serosa form sinus tracts connect to adjacent bowel, bladder, vagina, or skin 7

Thats why the question is NOT Should I go with acetyl glutathione or liposomal? You need to ask yourself Why is my glutathione low in the first place? Why Glutathione Can Be Low There are two main reasons this can happen